Chaplet Pharmaceutical Private Limited
About Chaplet Pharmaceutical Private Limited
Data last updated:
Chaplet Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2009PTC193011. Its GSTIN is 08AAECC2418D1Z4 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Harish Chaudhary and Omprakash Prajapat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 304 Delhi Chamber, 3453 Delhi Gate, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.51 Lakh (net margin 3.2%) and EBITDA of ₹5.07 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Chaplet Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRoom No. 304 Delhi Chamber, 3453 Delhi Gate, New Delhi, Delhi, India – 110002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Chaplet Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chaplet Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chaplet Pharmaceutical Private Limited, buy the company report.
Financials of Chaplet Pharmaceutical Private Limited
FY 2025 filings availableChaplet Pharmaceutical Private Limited reported revenue of ₹1.08 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 7% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chaplet Pharmaceutical Private Limited, buy the company report.
Board of directors of Chaplet Pharmaceutical Private Limited
Chaplet Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Chaudhary | Director | 10 Aug 2009 | 17 Years 2 Months | Current |
| Omprakash Prajapat | Director | 10 Aug 2009 | 17 Years 2 Months | Current |
| Ramesh Kumar | Director | 10 Aug 2009 | 17 Years 2 Months | Current |
Auditor
Chaplet Pharmaceutical Private Limited is audited by ARVIND VERMA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARVIND VERMA & CO. | FY 2024 | 0009037C |
Shareholding
The shareholding of Chaplet Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chaplet Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Chaplet Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chaplet Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Chaplet Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECC2418D1Z4 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chaplet Pharmaceutical Private Limited, buy the company report.
Recent activity
Chaplet Pharmaceutical Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Harish Chaudhary was appointed as Director on 10 Aug 2009.
Frequently asked questions
Chaplet Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 August 2009 (17+ years old) and is registered under CIN U24232DL2009PTC193011.
Chaplet Pharmaceutical has 3 current directors:
- Harish Chaudhary - Director
- Omprakash Prajapat - Director
- Ramesh Kumar - Director
The latest financial statements of Chaplet Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Chaplet Pharmaceutical is 08AAECC2418D1Z4, registered in Rajasthan.
The CIN (Corporate Identification Number) of Chaplet Pharmaceutical is U24232DL2009PTC193011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chaplet Pharmaceutical was incorporated on 10 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Harish Chaudhary was appointed as Director on 10 Aug 2009. Omprakash Prajapat was appointed as Director on 10 Aug 2009. Ramesh Kumar was appointed as Director on 10 Aug 2009.
The registered office of Chaplet Pharmaceutical is at Room No. 304 Delhi Chamber, 3453 Delhi Gate, New Delhi, Delhi, India – 110002.
Chaplet Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Chaplet Pharmaceutical is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.